News and events

ASU Biodesign Clinical Testing Laboratory receives coveted CAP accreditation

November 2, 2021

The Biodesign Clinical Testing Laboratory at Arizona State University has received accreditation from the College of American Pathologists (CAP), the nation’s largest organization of board-certified pathologists. The CAP Accreditation Committee has awarded accreditation based on results of rigorous onsite inspection as part of the CAP’s accreditation programs. Since the start of the pandemic, the Biodesign Institute at ASU has dedicated its specialized resources to mass testing for...

Update on COVID-19 Vaccine-Induced Neutralizing Antibodies Using a Rapid Test

October 26, 2021

Doug Lake, PhD, Biodesign Virginia G. Piper Center for Personalized Diagnostics and Biodesign Center for Immunotherapy, Vaccines and Virotherapy, will present as part of the Biodesign Center for Immunotherapy, Vaccines and Virotherapy Wednesday Seminar Series. Join via Zoom: https://asu.zoom.us/j/88567521236

ASU research on protein responsible for detection, regulation of body temp part of collection marking Nobel Prize

October 8, 2021

The 2021 Nobel Prize in Physiology or Medicine was awarded on Oct. 3 to David Julius and Ardem Patapoutian "for their discoveries of receptors for temperature and touch." To celebrate, the journal Nature Portfolio presented a collection including further exciting research focused on different aspects of TRP and PIEZO channels, proteins that sense these ubiquitous stimuli. Included in the collection is a paper published by scientists from Arizona State University's School of...

Organ regeneration, biologics for transplantation and wound healing

October 6, 2021

Biodesign China Virtual Symposium Alexandra Lucas, Biodesign Virginia G. Piper Center for Personalized Diagnostics and Bi-Sen Ding, State Key Lab of Biotherapy, Sichuan University will share presentations. Participants can engage in a meaningful discussion following the presentations.   This seminar is part of a virtual fall symposium, hosted by Biodesign Institute China, West China Hospital in Chengdu, and the Biodesign Institute at Arizona State...

Mass spec detection of metabolites

October 6, 2021

Biodesign China Virtual Symposium Chad Borges, Biodesign Virginia G. Piper Center for Personalized Diagnostics​​ and Bingwu Ying, West China Hospital of Sichuan University will share presentations. Participants can engage in a meaningful discussion following the presentations.   This seminar is part of a virtual fall symposium, hosted by Biodesign Institute China, West China Hospital in Chengdu, and the Biodesign Institute at Arizona State...

Serpins and Immune Modulation - From Vasculitis and Lupus to COVID-19

September 15, 2021

Professor Alex Lucas, M.D., Biodesign Virginia G. Piper Center for Personalized Diagnostics, is presenting as part of the Biodesign Center for Immunotherapy, Vaccines and Virotherapy Wednesday Seminar Series. Join us via Zoom: https://asu.zoom.us/j/88567521236

SARS-CoV-2: a theme and variations

August 11, 2021

The celebrations were well underway. America seemed to be emerging from the depths of the COVID-19 crisis, following some of the darkest days in the nation’s history. A vast reduction in infections, hospitalizations, and fatalities, driven by improved therapies and above all, a suite of highly effective vaccines, had brought a collective sigh of relief. The July 4th festivities were euphorically anticipated, marking not only the nation’s independence from colonial rule but its...

Translating innovation from the lab to the marketplace

June 18, 2021

Academic entrepreneurs looking to translate their research from the lab to the marketplace often face a daunting challenge: the valley of death. This is the point in the innovation cycle where many technologies meet their demise. It represents the period when opportunities for governmental funding that support fundamental science breakthroughs have been exhausted, at the same time when industry investors are waiting for more testing and finishing touches. For researchers at Arizona...

Variances in critical protein may guide fate of those infected with SARS CoV-2

March 22, 2021

Of the many perplexing questions surrounding SARS CoV-2, a mysterious new pathogen that has killed an estimated 2.6 million people worldwide, perhaps the most insistent is this: why does the illness seem to strike in such a haphazard way, sometimes sparing the 100 year old grandmother, while killing healthy young men and women in the prime of life? A new study by Karen Anderson, Abhishek Singharoy and their colleagues at the Biodesign Institute at Arizona State University, may offer some...

ASU develops state’s first saliva-based COVID-19 test

May 29, 2020

In an effort to make COVID-19 diagnostic testing easier and more readily available to Arizonans, researchers at Arizona State University have developed the state’s first saliva-based test. “This new saliva-based test will be a real game-changer for those individuals who want to know whether or not they have an active COVID-19 infection,” said ASU Biodesign Institute Executive Director Joshua LaBaer, who leads ASU COVID-19 research efforts. “As we return to the workplace, schools...